Patient selection for corneal collagen cross-linking: An updated review

Virgilio Galvis, Alejandro Tello, Alvaro I. Ortiz, Luis C. Escaf

Research output: Articles / NotesArticle in a non-specialized journalpeer-review

28 Scopus citations


Corneal cross-linking (CXL) is an option that in the last decade has demonstrated its efficacy and safety in halting the progression of keratoconus (KCN) and other corneal ectasias. Its indication has been extended beyond the classic definition that required evidence of KCN progression, especially in the presence of some risk factors for a possible progression (particularly the younger age). However, the results can be still somewhat variable today. There are several protocols, each with its own advantages and disadvantages. Some predictors of CXL outcome have been identified. We will review the current knowledge on patient selection for CXL, its indications, and options in special cases (such as thin corneas).

Original languageEnglish
Pages (from-to)657-668
Number of pages12
JournalClinical Ophthalmology
StatePublished - 7 Apr 2017


  • Cornea
  • Corneal collagen cross-linking
  • Cross-linking
  • Keratoconus
  • Keratoectasia


Dive into the research topics of 'Patient selection for corneal collagen cross-linking: An updated review'. Together they form a unique fingerprint.

Cite this